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In developmental biology, gradients of bioactive signals direct the formation of structural transitions in
tissue that are key to physiological function. Failure to reproduce these native features in an in vitro
setting can severely limit the success of bioengineered tissue constructs. In this report, we introduce a
facile and rapid platform that uses magnetic ﬁeld alignment of glycosylated superparamagnetic iron
oxide nanoparticles, pre-loaded with growth factors, to pattern biochemical gradients into a range of
biomaterial systems. Gradients of bone morphogenetic protein 2 in agarose hydrogels were used to
spatially direct the osteogenesis of human mesenchymal stem cells and generate robust osteochondral
tissue constructs exhibiting a clear mineral transition from bone to cartilage. Interestingly, the smooth
gradients in growth factor concentration gave rise to biologically-relevant, emergent structural features,
including a tidemark transition demarcating mineralized and non-mineralized tissue and an osteo-
chondral interface rich in hypertrophic chondrocytes. This platform technology offers great versatility
and provides an exciting new opportunity for overcoming a range of interfacial tissue engineering
challenges.
© 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Biological gradients play an essential role in deﬁning the func-
tional role of a wide range of tissues, including tendon, cartilage
and the central nervous system [1e3]. These gradients are largely
dictated by an anisotropic distribution of growth factors present
during embryological development and pre-adolescent growth. For
instance, the formation of the cartilage-bone interface in osteo-
chondral tissue is heavily inﬂuenced by a polarized distribution of
pro-osteogenic growth factors, such as bone morphogenetic pro-
tein 2 (BMP-2) [3,4]. These local differences in growth factor con-
centration produce spatial variance in cell signaling, which can, in
turn, lead to distinct cell phenotypes across the tissue (e.g. osteo-
blasts and chondrocytes). In a structural system such as osteo-
chondral tissue, the different cell types sculpt the ﬁnal tissue
composition via the production and remodeling of different
extracellular matrix components. These structural features play atevens).
r Ltd. This is an open access articlecritically important role in the functional performance of the tissue;
for instance, the gradual transition between bone and cartilage
enables the smooth transmission and distribution of compressive
loads through the osteochondral tissue [5,6].
Despite these well-known considerations, the overwhelming
majority of in vitro engineering strategies use uniform scaffolds and
homogeneous growth factor delivery to produce isotropic tissue
constructs. It is clear that more sophisticated fabrication processes
are required to replicate the native complexity and fulﬁll the
functional requirements of tissue grafts. A few material strategies
have been developed that can heterogeneously deliver biological or
mechanical cues [7e11]. A simplistic strategy, which has found
clinical application, is to laminate separate biomaterials by suture
or other approaches such as using a small amount of solvent after
preparation [4,12]. This approach uses the material composition
and structure of the different scaffold layers to direct cell fate and
tissue formation, however, discontinuities at the interface make
these biphasic materials highly susceptible to delamination [8]. A
smoother transition can be achieved using a gradient maker, in
which microspheres laden with growth factors are distributed inunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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techniques, such as photo-patterning [14] and microﬂuidics [14].
These systems can produce excellent gradients, but can often be
limited by complex micro-fabrication procedures or compatibility
with different material systems. It is clear that there is an urgent
and unmet need for a simple and versatile gradient casting method
that can be universally applied to different biomaterial and tissue
engineering protocols.
To this end, we present a new strategy in which externally-
applied magnetic ﬁelds are used to decorate different bio-
materials with continuous gradients of growth factor loaded gly-
cosylated superparamagnetic iron oxide nanoparticles (SPIONs)
(Fig. 1). SPIONs have previously been used to generate polarization
of the signaling protein RanGTP within Xenopus egg extracts to
spatially modify the assembly of microtubule networks [15]. To the
best of our knowledge, however, SPIONs have not yet been inves-
tigated as amethod for patterning biochemical gradients for in vitro
tissue engineering. Here, we report the use of magnetically-aligned
gradients of BMP-2 to spatially direct mineralization during
osteochondral tissue engineering. Speciﬁcally, we used an external
magnetic ﬁeld to pattern glycosylated SPIONs into an agarose
hydrogel, pre-laden with human mesenchymal stem cells (hMSCs).
Thermal gelation of the hydrogel enabled us to stably encapsulate a
BMP-2 gradient, which was used to spatially stimulate osteogenic
gene expression and tissue mineralization over a 28-day culture.
The resulting tissues exhibited a cartilage region, rich in type II
collagen and glycosaminoglycan, with a transition into a mineral-
ized, bone region exhibiting extensive distribution of b-tricalcium
phosphate (b-TCP) and hydroxyapatite (HAP). In certain cases,
these differences in extracellular matrix provided an increased
compressive instantaneous modulus at the bone region compared
to the cartilage region. This approach required no specialized
equipment, other than a magnet, and offered great versatility in
patterning different hydrogel or scaffold systems. The ability to
produce tissue-scale biochemical gradients in under a minuteFig. 1. Engineering osteochondral tissue using magnetically-aligned glycosylated
SPIONs. (A) SPIONs are conjugated with heparin to produce a glycosylated corona that
can efﬁciently sequester and release growth factors. (B) An external magnetic ﬁeld is
used to ﬁeld-align glycosylated SPIONs in a hMSC-laden agarose hydrogel, which is
thermally gelled and cultured for 28 days to generate robust osteochondral constructs
comprising both bone and cartilage tissue.across different biomaterials should afford this platform technology
wide applicability across a range of complex tissue engineering
systems.
2. Materials and methods
2.1. Glycosylated SPION synthesis and characterization
A 0.9mL solution of 1.5mgmL1 of heparin (Sigma Aldrich, UK)
was prepared in pH 5.4 4-morpholineethanesulfonic acid buffer
(MES, Thermo Fisher, USA), and mixed for 15min with 5mg of N-
(3-dimethylaminopropyl)-N0-ethylcarbodiimide hydrochloride
(EDC, Sigma Aldrich, UK) and 1mg of N-hydroxysuccinimide (NHS,
Sigma Aldrich, UK). 0.1mL of 5mgmL1 amine-functionalized
20 nm SPIONs (SHA-20, Ocean NanoTech, USA) were then added
and mixed for 24 h at room temperature. After the conjugation, the
product was dialyzed against 5 L of phosphate-buffered saline (PBS,
Thermo Fisher, USA) for 3 days with two daily buffer changes to
ensure complete removal of unconjugated heparin. The conjugated
SPIONs were then concentrated to 2mgmL1 using 100 kDa cut-off
Amicon ultra-centrifugal ﬁlter unit (Merck Millipore, USA).
Zeta potential and hydrodynamic diameter measurements were
performed using a Zetasizer Zen 3600 (Malvern Instruments, UK),
with samples in pH 7 deionized water at a concentration of
40 mgmL1. Heparin quantiﬁcation was performed using dime-
thylmethylene blue (DMMB, Sigma Aldrich, UK), with standards
ranging between 0 and 25 mgmL1 and an unconjugated SPION
reference. The absorbance was measured at 525 nm using a Spec-
traMax M5 microplate reader (Molecular Devices, USA). The
sulfated glycosaminoglycan content was normalized to the nano-
particle number, which was measured using a Nanosight (Ns300,
Malvern Instruments, UK) equipped with Nanoparticle Tracking
Analysis 3.0 software. Magnetic analysis was performed using a
SQUID magnetometer (MPMS-7, Quantum Design, UK) on
1.5mgmL1 samples. These values were normalized by iron con-
tent, which was measured by digesting the nanoparticles in 2 N
nitric acid (Sigma Aldrich, UK) at 40 C for 24 h to ensure complete
digestion and analyzing samples using inductively coupled plasma
optical emission spectrometry (ICAP 6300 Duo, Thermo Fisher,
USA).
The protein loading capacity of the glycosylated SPIONs was
assessed by mixing avidin (Thermo Fisher, USA) with glycosylated
and unconjugated SPIONs at room temperature for 10min, and
then centrifuging the sample at 20,817 g for 100min. The concen-
tration of avidinwas detected using aMicro BCA™ Protein Assay Kit
(Thermo Fisher, USA) following the manufacturer's protocol, using
avidin standards between 0 and 20 mgmL1. The loading capacity
was determined by subtracting the initial loading mass of avidin
with the mass of avidin detected in the supernatant.
2.2. Magnetic ﬁeld alignment and simulation
Finite element magnetic modeling (FEMM, D. C. Meeker, Finite
Element Method Magnetics, Version 4.2.) was used to characterize
the magnetic ﬁeld based on the dimensions and physical properties
of the cylindrical N42 magnet (eMagnets, UK) used throughout the
study (ø¼ 20mm, height¼ 20mm, HcB¼ 915 kA/m). All gradients
were formed in a customized mold composed of two glass slides
and a cut 2mm silicone spacer (ﬁnal well di-
mensions¼ 13 5 2mm). 30 mL of solution or hydrogel precursor
containing SPIONs were dispensed into the mold, followed by 60 mL
of the same components minus the SPIONs. The magnetic ﬁeld was
subsequently applied from approximately 2mm above the mold to
redistribute the SPIONs into a gradient. To image the gradient for-
mation process, gradients were formed in deionized water using a
C. Li et al. / Biomaterials 176 (2018) 24e3326layer of 0.5mgmL1 SPIONs.
To examine the gradient forming capability in different hydro-
gels, a layer of 0.5mgmL1 SPIONs was used. After the formation of
the gradient, the hydrogel precursor was gelled and the constructs
were imaged using an Axio Observer invertedwideﬁeldmicroscope
(Zeiss, Germany). Type VII-A Agarose (Sigma Aldrich, UK) was used
at 1wt% and gelled at room temperature. Geltrex (Thermo Fisher,
USA) was used undiluted and gelled at 37 C. Gellum gum (Sigma
Aldrich, UK) was used at 0.75wt% and crosslinked by the addition
of a 0.06 wt% solution of calcium chloride. Gelatin (Sigma Aldrich,
UK) was used at 5wt% and gelled at 4 C. To visualize the distri-
bution of loaded protein, 1011 SPIONs were ﬁrst loaded with 300 ng
of ﬂuorescein-labelled avidin (Thermo Fisher, USA) prior to
gradient formation. Intensity plots were produced using the plot
proﬁle function on FIJI software using images acquiredwith an Axio
Observer inverted wideﬁeld microscope (Zeiss, Germany). 1 wt%
agarose was used to test the inﬂuence of viscosity on pattern for-
mation, with the gradient forming process carried out in a
temperature-controlled water bath (27, 30, 37 C) and the resulting
gels imaged using a desktop scanner. The viscosity of the agarose
solutions at these temperatures was measured by rheological creep
tests performed at 2 Pa stress over 5min using an AR2000ex
rheometer (TA Instruments, USA).
2.3. BMP-2 release kinetics
1011 glycosylated SPIONs loaded with 300 ng of BMP-2 (R&D
System, USA) were cast into a 100 mL 1wt% agarose hydrogel, to
mimic the conditions used for osteochondral tissue engineering.
The hydrogel was incubated in PBS with 0.02% of sodium azide (pH
7.4) (Sigma Aldrich, UK) at 37 C for 28 days. 500 mL of PBS was
removed at intervals and frozen at 20 C, with 500 mL of fresh PBS
added to the hydrogel to ensure that sink conditions were
respected at all times. The concentration of released BMP-2 was
then quantiﬁed using a BMP-2 speciﬁc ELISA kit (R&D System,
USA), following the manufacturer's protocol. The absorbance was
measured at 450 nm using a SpectraMax M5 plate reader. After the
accumulated release was determined for each time point, the
release proﬁle was ﬁtted by a Korsmeyer-Peppas model using
KinetDs (version 3.0) [16]. The Korsmeyer-Peppas Model was
developed to speciﬁcally model the release of molecules from a
polymeric matrix, such as hydrogel network [17].
2.4. Stem cell culture and differentiation
hMSCs from three donors (Lonza, Switzerland) were expanded
using Mesenchymal Stem Cell Growth Medium (MSCGM™, Lonza,
Switzerland) in sterile culture at 37 C/5% CO2. The culture medium
was changed every 2e3 days, and hMSCs cultured up to passage 5.
Differentiation was induced after encapsulating the hMSCs into
agarose hydrogels at a cell density of 9 106 hMSCs per mL.
Osteogenic differentiation was triggered using high glucose Dul-
becco's Modiﬁed Eagles Medium with pyruvate supplement (HG-
DMEM 31966021, Thermo Fisher, UK) together with 10% (v/v) fetal
bovine serum (FBS, Thermo Fisher, USA), 100 nM dexamethasone
(Sigma Aldrich, UK), 50 mgmL1 L-ascorbic acid 2-phosphate ses-
quimagnesium salt (L-ascorbic acid, Sigma Aldrich, UK) and 10 mM
b-glycerophosphate (Sigma Aldrich, UK). Chondrogenic differenti-
ation was triggered using HG-DMEM supplemented with 1X ITSþ
(BD, USA), 100 nM dexamethasone, 50 mg mL1 L-ascorbic acid,
50 mgmL1 L-proline (Sigma Aldrich, UK) and 10 ngmL1 trans-
forming growth factor b3 (TGF-b3) (R&D System, USA). Osteo-
chondral differentiation was triggered using HG-DMEM
supplemented with 1X ITSþ, 100 nM dexamethasone, 50 mgmL1 L-
ascorbic acid, 50 mgmL1 L-proline, 2mM b-glycerophosphate and10 ngmL1 TGF-b3. Where stated, BMP-2 was supplemented either
in the medium (30 ngmL1) or loaded together with glycosylated
SPIONs. Unless otherwise speciﬁed, the BMP-2 concentration in the
glycosylated SPIONs was 3 mg per mL of hydrogel.2.5. Tissue engineering osteochondral gradients
1011 glycosylated SPIONs were incubated with 300 ng of BMP-2
at 4 C for at least 5 h and then used to create a gradient in agarose,
as described previously. hMSCs were included in both layers during
the fabrication process, at a concentration of 9 106 hMSCs per mL,
and the ﬁnal concentration of BMP-2 was 3 mgmL1. The gradient
hydrogel was transferred into a 24-well plate and cultured in 1mL
of osteochondral differentiation medium. The medium was
changed after 2 h and the next day after seeding to remove the
excess initial burst release BMP-2, and then three times a week for
the remaining 27 days.2.6. Gene expression analysis
Osteochondral tissue constructs engineered from three donors
(N¼ 3, n¼ 3) were harvested and dissected into three equal pieces.
The cartilage and bone ends were rinsed with PBS, homogenized
using a TissueLyser II (Qiagen, Germany), and then stored at80 C.
Total RNA was isolated using Trizol with Direct-zol™ RNA Kits,
according to the manufacturer's protocol, and quantiﬁed using a
NanoDrop 2000c (Thermo Fisher, UK). RNA was used to generate
cDNA using a QuantiTect® Reverse Transcription Kit (Qiagen, Ger-
many), assuming a 1:1 conversion. Quantitative PCRwas performed
using 3 ng of cDNA, Taqman® probes (Thermo Fisher, USA) and a
StepOnePlus™ (Thermo Fisher, USA). The following probes were
used: RPL13A (Hs04194366_g1), ACAN (Hs00153936_m1), ALPL
(Hs01029144_m1), COL1A1 (Hs00164004_m1), COL2A1
(Hs00264051_m1), COL10A1 (Hs00166657_m1), RUNX2
(Hs01047973_m1), SOX9 (Hs00165814_m1), SP7 (Hs01866874_s1).
The DDCt method was used to compare expression at the bone
region normalized to the cartilage region.2.7. ALP and DNA assays
Osteochondral tissue constructs (N¼ 3, n¼ 3) were harvested
and dissected, as previously described. The ALP activity and quan-
tity of DNA was determined using a protocol modiﬁed from the
literature [18]. The bone and cartilage ends of the tissue were ho-
mogenized separately using a TissueLyser II with ALP lysis buffer,
consisting of 1mMMgCl2 (Sigma Aldrich, UK), 20 mM ZnCl2 (Sigma
Aldrich, UK) and 0.1% (w/v) octyl-b-glucopyranoside (Sigma
Aldrich, UK) in 10mM tris(hydroxymethyl)aminomethane buffer
(pH 7.4) (Sigma Aldrich, UK) with the sample lysate immediately
stored at80 C. To perform the assay, the samples were thawed on
ice and then each sample was incubated with p-nitrophenol
phosphate (Sigma Aldrich, UK) at 37 C for 30min. The reactionwas
terminated using 1 N NaOH and the absorbance measured at
405 nm using a SpectraMax M5 plate reader. A standard curve
between 0 and 800 mM of p-nitrophenol phosphate was used to
calculate the sample activity. An equivalent volume from the
remainder of the sample was then used for DNA quantiﬁcation
using a PicoGreen™ assay (Thermo Fisher, UK), according to the
manufacturer's protocol. The ﬂuorescence was measured at 485/
535 nm using a SpectraMax M5 plate reader. The ALP activity
normalized to DNA quantity was compared between the bone and
cartilage regions.
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Osteochondral tissue constructs were harvested and washed
three times in PBS, ﬁxed with 4% (v/v) paraformaldehyde for 2 h at
room temperature, washed a further three times in PBS and then
parafﬁn embedded. 5 mm thick sections on Superfrost Plus slides
(Thermo Scientiﬁc, UK) were deparafﬁnized using a 4min incuba-
tion in Histo-Clear (National Diagnostics, USA) and hydrated using
2min incubations in 100% ethanol, 70% ethanol and then deionized
water. These sectionswere then stained using various protocols. For
sulfated glycosaminoglycans, the sections were stained with Alcian
Blue (pH 2.5) (Sigma Aldrich, UK) for 30min, with a hematoxylin
nuclear counterstain (Sigma Aldrich, UK). For calcium, Alizarin Red
S (Abcam, UK) was used at a concentration of 2% (w/v) at pH 4.3.
Alcian Blue and Alizarin Red S were performed on consecutive
sections. The slides were mounted in Histomount (National Di-
agnostics, USA) and then imaged using a Zeiss Axio Observer
Inverted Wideﬁeld Microscope. Images were superimposed after
tiling.
For immunoﬂuorescence staining, the sections were treated
with proteinase K (Dako, USA) for antigen retrieval, and then
blocked with 10% (v/v) donkey or goat serum. The samples were
incubated overnight with goat anti type I collagen (Southern
Biotech, USA) at 1/100 dilution, goat anti type II collagen (Southern
Biotech, USA) at 1/20 dilution, rabbit anti osteopontin and rabbit
anti type X collagen (Abcam, UK) at 1/100 dilution and goat and
rabbit IgG negative controls (Abcam, UK) at 1/20 and 1/100 dilution.
Excess primary antibody was then removed by three washes in PBS
and sections were further incubated with secondary donkey anti
goat or goat anti rabbit antibodies labelled with AlexaFluor 555 dye
(Thermo Fisher, USA). DAPI (Thermo Fisher, USA) was used to
counterstain the nucleus prior to mounting the sections with
Vectashield AntifadeMountingMedium (Vector Lab, USA). Sections
were imaged using a Zeiss Axio Observer Inverted Wideﬁeld
Microscope.
2.9. Compression testing
Osteochondral tissue constructs were harvested, with uniform
discs collected from the bone and cartilage regions using 2mm
biopsy punches (Miltex, USA). The biopsy dimensions were
measured in the hydrated state using digital calipers for each
construct, which were then soaked and tested in cOmplete™ Pro-
tease Inhibitor Cocktail (Roche, Switzerland). Unconﬁned
compression testing was performed using a Bose Electroforce 3200
(BOSE, USA) equipped with a 250 g load cell. Compression stress
relaxation tests were performed by imposing a square wave ramp
for 12 steps of 5% strain with a 360 s hold using Wintest 7 (BOSE,
USA). The instantaneous loadwas recorded at the beginning of each
step and used to produce an instantaneous stress-strain data set,
which was ﬁtted with a bilinear model using Origin (OriginLab
Corporation, USA). The instantaneous compressive modulus was
then calculated using the low-strain linear region of the stress-
strain curve and compared between the bone and cartilage regions.
2.10. Raman spectroscopy
Raman spectroscopic imaging was performed using a confocal
Raman microscope (alpha300Rþ, WITec, Germany) equipped with
a 532 nm laser and a x 20/0.4 NA objective lens (EC Epiplan, Zeiss,
Germany). The scattered light was coupled to the spectrometer via
a 100 mm ﬁber which functioned as the confocal pinhole. A 600
lines per mm grating spectrograph (UHTS 300, WITec, Germany)
and a thermoelectrically cooled back-illuminated CCD camera
(Newton DU970N-BV-353, Andor, UK) yielding a spectral resolutionof ~10 cm1 (deﬁned at full width at half maximum of mercury
argon emission lines) were used to record spectrawith 35mW laser
power at the sample. Full cross-sectional images with a 10 10 mm
step-size were acquired with 0.5 s integration time while higher
spatial resolution maps were recorded with 2 2 mm step size.
Raman spectra were corrected for the instrument response of the
system using a traceable Raman standard (STM-2245, National
Institute of Standards and Technology). Engineered osteochondral
tissue samples were prepared as previously described. After
parafﬁn embedding and sectioning to 20 mm thickness on Super-
frost Plus microscope slides, a standard dewaxing procedure was
performed to remove confounding spectral signatures from the
parafﬁn. Substrate signal was apparent in the acquired spectra in
regions of low mineralization but did not affect the determination
of mineral or cellular signatures. Full cross-sectional mineral pro-
ﬁles were calculated by integrating the measured HAP and TCP
intensities (945 - 975 cm1) at each position along the construct
length. High spatial resolution maps correspond to HAP (n1 PO4 at
962 cm1), bTCP (n1 HPO42 at 948 cm1), and cellular compo-
nents of lipids and proteins (nas,s CH2 at 2850e3000 cm1), which
were experimentally validated in agreement with literature [19].2.11. Cytotoxicity of glycosylated SPIONs
9.6 103 hMSCs were seeded in a 96 well plate and left to
adhere overnight before a 72 h incubationwith 2 1011 or 10 1011
glycosylated SPIONs per mL of culture medium. The cytotoxicity of
the glycosylated SPIONs was assessed using an alamarBlue assay
(Thermo Fisher, USA), as per the manufacturer's instructions, with
an incubation time of 3 h. The ﬂuorescence was measured at 570/
585 nm using an EnVision™ plate reader (Perkin Elmer, USA). The
metabolic activity was normalized to an untreated control and
averaged across three hMSC donors. hMSCs were also stained using
a LIVE/DEAD™ assay (L3224, Thermo Fisher) and imaged using an
IX51 Inverted microscope (Olympus, Japan).2.12. Statistical analysis
Comparison between experimental groups was conducted using
ordinary least-squares regression based on Generalized Linear
Models in the statistical software R using the rms package. When
appropriate, the data from the bone end of each individual
construct was normalized to the cartilage end for direct pairwise
analysis. The normalized data was then modelled as the dependent
variable, and regression coefﬁcients were calculated for indepen-
dent variables. To account for different levels of response due to cell
donor variability, generalized estimating equations were used (as
previously described) to enable clustering of measurements ob-
tained from constructs derived from a single donor [20e22]. The
generated regression coefﬁcients were compared. Speciﬁcally for
this analysis, the relative changes of interest were the gene
expression, enzyme activity, or mechanical properties (categorical).
These descriptors were included as independent variables. Heter-
oscedasticity in the data set was addressed by using the robust
covariance function created in the rms package (“robcov”) to adjust
the standard errors. Finally, to compare groups, a Welch's t-test (for
two group comparisons) or a one sample Student's t-test was
performed on the generated GLM regression coefﬁcients from the
developed regression model, which were represented with p-
values. All hypothesis tests were considered one-tailed based on
the hypothesis of increased values in the bone end of the construct
relative to the cartilage end, with exceptions for cell viability and
expression levels of chondrogenic genes (ACAN, COL2A1, and SOX9).
Table 1
Biophysical characterization of glycosylated SPIONs (mean ± standard deviation).
Scattering Analysis Magnetic Characterization Biochemical Proﬁle
Hydrodynamic
Diameter/nm
Zeta
Potential/
mV
Magnetic Susceptibility/101
emu g1 Oe1
Magnetic Saturation/
emu g1
Degree of Glycosylation/ng per
109 SPIONs
Protein Sequestered/ng per
109 SPIONs
Unconjugated
SPIONs
48.6 (±0.2) 4.7 (±0.6) 5.2 (±0.0) 54.9 (±0.3) N/A 1.5 (±0.3)
Glycosylated
SPIONs
72.3 (±0.9) 54.4 (±1.7) 5.4 (±0.0) 53.6 (±0.4) 4.2 (±0.5) 4.7 (±0.2)
C. Li et al. / Biomaterials 176 (2018) 24e33283. Results and discussion
In order to generate biochemical gradients, we glycosylated
20 nm SPIONs with a protein-binding corona of heparin. Brieﬂy, we
used a carbodiimide-based coupling to conjugate the carboxylate
groups of heparin to primary amines present on the nanoparticle
surface. We then characterized the glycosylated SPIONs, which
were colloidally stable, using dynamic light scattering in order to
determine the size and surface charge potential (Table 1). The hy-
drodynamic diameter increased from 48.6± 0.2 nm for the bare
nanoparticles to 72.3± 0.9 nm after glycosylation, which was
attributed to the steric bulk of the heparin corona. The glycosylated
SPIONs exhibited a zeta potential of 54.4± 1.7mV compared
to 4.7± 0.6mV for the unconjugated nanoparticles, which was
further evidence for the binding of heparin, a highly anionic poly-
saccharide. We assessed the magnetic properties of the glycosy-
lated SPIONS using superconducting quantum interference device
(SQUID)magnetometry correlatedwith inductively coupled plasma
optical emission spectroscopy (ICP-OES). The glycosylated SPIONs
exhibited a magnetic susceptibility of 5.4± 0.0 101 emu g1
Oe1 and a saturation of 53.6± 0.4 emu g1, values that were very
similar to the unconjugated nanoparticles (5.2± 0.0 101 emu
g1 Oe1, 54.9± 0.3 emu g1) (Table 1).
Next, we measured the degree of glycosylation using nano-
particle tracking analysis and a dimethylmethylene blue (DMMB)
assay (Supplementary Figure 1 and Table 1). These results revealed
4.2 ng of heparin per 109 nanoparticles, a value that corresponded
to approximately 140 heparin chains bound to the surface of each
nanoparticle. The high density of carboxylate groups on heparinFig. 2. Magnetic ﬁeld alignment of SPIONs. (A) Finite element modeling of the magnetic ﬁeld
of SPIONs (brown) in water, with a clear transition from a biphasic stack to a smooth gradien
in different biomaterials. Scale bar in all images¼ 2mm. (For interpretation of the referencesprovides an anionic network that can be used to sequester many
soluble proteins. For example, our protein of interest, bone
morphogenetic protein 2, exhibits highly basic N-terminal peptide
domains that confer a high binding afﬁnity with heparin
(kDz 20 nM) [23]. To assess the sequestration of the glycosylated
SPIONs, we used avidin as a model protein, due to its similar iso-
electric point, comparable dissociation constant (kDz 160 nM)
and the fact that it is commonly used as an analogue for studying
the interaction between BMP-2 and heparin [24,25]. A bicincho-
ninic acid assay of avidin revealed an average of 4.7± 0.2 ng of
avidin incorporated per 109 nanoparticles, approximately four
times greater than observed for the unconjugated SPIONs, and
equivalent to approximately 40 sequestered proteins per nano-
particle. This loading capacity offered the opportunity to deliver
more than 400 ng of growth factors, a quantity sufﬁcient to inﬂu-
ence cell fate, using only 1011 nanoparticles [26]. Importantly, the
glycosylated SPIONs did not signiﬁcantly affect the viability of
hMSCs, as demonstrated using alamarBlue and LIVE-DEAD™ assays
performed after a 72-h exposure to glycosylated SPIONS (1012
nanoparticles per mL) (Supplementary Figure 2).
Next, we investigated the nanoparticle response to externally-
applied magnetic ﬁelds in aqueous solution and different hydro-
gels commonly used for in vitro tissue engineering. Here, we used
ﬁnite element magnetic modeling to characterize the magnetic
ﬁeld strength and distribution (Fig. 2A). This map enabled us to
deﬁne the relative positions of the magnet and nanoparticle solu-
tion, in order to expose the SPIONs to a well-deﬁned ﬁeld gradient
(from 0.1 to 0.4 T) (Supplementary Figure 3). We initially used these
ﬁeld parameters to attract SPIONs dispersed in a monophasicstrength and distribution. (B) Time-lapse images showing the magnetic ﬁeld alignment
t. (C) Bright ﬁeld microscopy images showing gradients of SPIONs (brown) immobilized
to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
Fig. 3. BMP-2 release and action in agarose hydrogels. (A) An ELISA was used to detect
the release of BMP-2 from glycosylated SPIONs immobilized in 1wt% agarose, over a
period of 28 days. (mean ± S.D., n¼ 3). The BMP-2 release proﬁle from agarose to the
surrounding medium was ﬁtted using the Korsmeyer-Peppas model (R2¼ 0.97). (B)
Alizarin Red S staining in tissue engineered hMSC-laden agarose constructs with or
without glycosylated SPIONs loaded with BMP-2. Extensive calcium deposition (red)
was observed in the hydrogel with BMP-2 present, with no staining in the system
without BMP-2. Scale bars¼ 200 mm. (C) Macroscopic view of a representative osteo-
chondral tissue construct engineered using agarose hydrogels patterned with a SPION
gradient of BMP-2. An opaque mineralized region can be clearly observed at the bone
end of the tissue construct. Scale bars¼ 1mm (D) For the gradient constructs, bright
ﬁeld microscopy showed a smooth transition from the cartilage region to the bone
region. A control system using a biphasic layered stack, rather than a gradient,
exhibited a clear margin between the two regions of the tissue. Scale bars¼ 1mm. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to
the Web version of this article.)
C. Li et al. / Biomaterials 176 (2018) 24e33 29suspension, however, this process took several hours (>16 h) to
reach completion and produced a thin layer of aggregated SPIONs
rather than a gradient transition. We resolved this issue by starting
with a two-phase system, in which nanoparticle-free solution was
stacked on top of a suspension of nanoparticles. Applying a mag-
netic ﬁeld from above resulted in a rapid redistribution of the two
layers to generate a smooth nanoparticle gradient (<5 s) (Fig. 2B).
Continued exposure to themagnetic ﬁeld eventually resulted in the
SPIONs forming dense aggregates close to the magnet. This tran-
sition was a slow process (>10 h), which afforded ample time to
capture the system in a non-equilibrium state by encapsulating the
nanoparticle gradient in a hydrogel. Indeed, this process appeared
to be largely independent of the material type or crosslinking
mechanism, however, we did identify three key characteristics that
favored gradient formation. First, the SPIONs should be colloidally
stable in the precursor solution; which was not the case for certain
gels at high weight fraction (e.g.> 5wt% agarose). Second, the
precursor solution should not inhibit SPION movement through
viscous drag; no gradient formation was observed in 1% agarose
gels maintained as a highly viscous solution at 27 C
(Supplementary Figure 4). Third, the crosslinking mechanism
should be reasonably rapid (<1 h), and preferably triggered, in or-
der to capture the SPIONs in a non-equilibrium gradient distribu-
tion. These characteristics are exhibited by the majority of
hydrogels used for tissue engineering. Indeed, we successfully
demonstrated the formation of SPION gradients in a range of bio-
materials, including gelatin, Geltrex™, Gelzan™ and agarose
(Fig. 2C). Importantly, we could use this system to generate protein
gradients in biomaterials, as demonstrated by ﬂuorescent micro-
scopy of an agarose hydrogel patterned with glycosylated SPIONs
containing ﬂuorescently-tagged avidin (Supplementary Figure 5A).
The protein cargo was well co-localized with the nanoparticles, and
importantly, the magnetic ﬁeld alignment produced a much
smoother transition than a biphasic stacking approach, which
resulted in a much sharper boundary at the layer interface
(Supplementary Figure 5B).
We applied this hydrogel patterning approach to the complex
and clinically-relevant challenge of osteochondral tissue engi-
neering. Native osteochondral tissue possesses a structural transi-
tion from hyaline cartilage to the underlying subchondral bone that
is generated in the developmental process of endochondral ossiﬁ-
cation. A key biochemical cue present during tissue development is
the pro-osteogenic growth factor BMP-2. Gradients of BMP-2 in the
growth plate play an important role in spatially regulating chon-
drocyte proliferation and hypertrophic differentiation in vivo [3,27],
while in vitro studies have shown that BMP-2 can trigger bone
formation in a concentration-dependent manner [28]. Like many
cationic growth factors, BMP-2 exhibits a high afﬁnity for heparin
(kD¼ 20 nM) [23], which has been used in tissue engineering
systems to guard against degradation and provide sustained release
and stimulation [29,30]. To test whether our system could be used
to release growth factors in a biomaterial system, we immobilized
BMP-2 loaded glycosylated SPIONs in agarose hydrogels and then
monitored the release into solution using an enzyme-linked
immunosorbent assay (ELISA). This analysis revealed a sustained
diffusion-driven release (Korsmeyer-Peppas model ﬁtting,
R2¼ 0.97) of BMP-2 over 28 days, with 20% released after the ﬁrst
24 h (Fig. 3A). It should be noted that these measurements do not
account for any possible denaturation of BMP-2. Accordingly, we
sought to test the functional activity of the loaded glycosylated
SPIONs in a tissue engineering set up.
Here, we intend to use magnetic alignment to present glycosy-
lated SPIONs loaded with BMP-2 as a gradient across a hMSC-laden
agarose hydrogel. The subsequent slow release of active BMP-2
over 28 days should stimulate hMSC osteogenesis and tissuemineralization predominantly at one end of the engineered
construct [31]. To ensure cartilage formation at the other end of the
tissue, we included TGF-b3 alongside insulin-transferrin-selenium,
ascorbic acid, dexamethasone and b-glycerophosphate in an opti-
mized osteochondral differentiation medium based on similar
compositions reported in the literature [13,32,33]. We used b-
glycerophosphate at a concentration of 2mM, a level that can
provide a source of phosphate without initiating osteogenesis or
nonspeciﬁc mineral precipitation [34]. Indeed, we showed that this
osteochondral medium could support either osteogenic or chon-
drogenic differentiation of hMSCs in agarose, depending on the
presence or absence of BMP-2 in the culture medium
C. Li et al. / Biomaterials 176 (2018) 24e3330(Supplementary Figure 6). More importantly, the osteochondral
medium supported tissue mineralization in a 28-day culture of
hMSCs in agarose with BMP-2 delivered exclusively via glycosy-
lated SPIONs (Supplementary Figure 7). Indeed, the total level of
BMP-2 loaded into the glycosylated SPIONswas often too high, with
a large excess of unconsumed growth factor capable of diffusing out
of the hydrogel and stimulating osteogenesis in adjacent,
nanoparticle-free constructs. We addressed this issue by opti-
mizing the level of BMP-2 in the glycosylated SPIONs to identify a
growth factor concentration (3 mgmL1) capable of producing only
local mineralization (Fig. 3B and Supplementary Figure 8).
Having optimized the gradient formation, growth factor release,
cell viability and differentiation for osteochondral tissue engi-
neering, we assembled the ﬁnal system with BMP-2 loaded glyco-
sylated SPIONs magnetically-aligned within a hMSC-laden agarose
hydrogel. Over 28 days of differentiation, the vast majority of the
tissue constructs developed striking white opacity at the bone end
of the constructs (Fig. 3C). It should be noted that approximately
10% of the engineered constructs failed to produce any visible
mineralization, and these were excluded from further study. In all
cases, however, the gradient hydrogels produced tissue constructs
that were structurally robust, with no macroscopic defects
observed between the bone and cartilage ends of the tissue. This
was in stark contrast with osteochondral tissue engineered fromFig. 4. Gene and protein expression in osteochondral tissue engineering. (A) Gene expressi
region. Comparison of differences were made using a one sample t-test after heteroscedastic
p < 0.05 (*), p < 0.01 (**). (B) Histological and immunoﬂuorescence staining of key extra
glycosaminoglycans (blue) and type I and II collagen (red). Scale bars ¼ 200 mm. (C) Immuno
key mineralization protein osteopontin (red), which were present speciﬁcally at the bone e
this ﬁgure legend, the reader is referred to the Web version of this article.)stacked, biphasic constructs, which produced a distinct 200 mm
margin between the two ends of the tissue (Fig. 3D). Further
investigation revealed that these margins were formed prior to
tissue culture, with the biphasic interface appearing to exclude
hMSCs (Supplementary Figure 9). The exact mechanism under-
pinning this observation is unknown, but nevertheless, the ability
to avoid such tissue defects represents a major advantage for our
gradient biomaterial over simple biphasic systems.
Alongside thesemacroscopic observations, we characterized the
osteochondral tissue gradient constructs after 28 days of culture
using gene expression analysis, histology and immunostaining.
Gene expression analysis using quantitative polymerase chain re-
action (qPCR) revealed signiﬁcant upregulation in the mRNA of
both chondrogenic genes (COL2A1, SOX9, ACAN) and osteogenic
genes (SP7, RUNX2, COL1A1, ALPL, COL10A1), compared to undiffer-
entiated hMSCs at day 0 (Supplementary Figure 10). The observed
upregulation indicated a positive effect of both the media-
supplemented TGF-b3 and the SPION-loaded BMP-2. More impor-
tantly, we observed a higher expression of osteogenic genes in the
bone region compared to the cartilage region (N¼ 3, n¼ 3)
(Fig. 4A). Signiﬁcantly upregulated genes included ALPL and
COL10A1, which are responsible for the expression of alkaline
phosphatase and type X collagen, respectively. Importantly, we
observed no signiﬁcant differences between the bone and cartilageon of ﬁve osteogenic genes at the bone region of the tissue, compared to the cartilage
ity in the dataset was addressed (mean ± 95% conﬁdence intervals, N ¼ 3, n ¼ 3) where
cellular matrix proteins present in cartilage and bone revealed deposition of sulfated
ﬂuorescence staining of the hypertrophic protein type X collagen (orange), and (D) the
nd of the tissue. Scale bars ¼ 200 mm. (For interpretation of the references to colour in
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(Supplementary Figure 11). This gene expression analysis strongly
indicated that the soluble TGF-b3 acted globally across the tissue,
while the magnetically-aligned gradient of BMP-2 inﬂuenced the
osteogenic differentiation of hMSCs in a spatially-deﬁned manner.
Furthermore, we showed that these differences in gene
expression could spatially inﬂuence matrix composition and
structure in the tissue constructs. Alcian Blue staining for sulfated
glycosaminoglycans and immunoﬂuorescence staining for type I
and II collagen revealed extensive extracellular matrix deposition,
with cells located in well-deﬁned lacunae (Fig. 4B). The presence of
these components was expected; glycosaminoglycan and type II
collagen are the two major components of physiological hyaline
cartilage, while type I collagen is commonly expressed in engi-
neered cartilage constructs, particularly those grown using hMSCs
[35]. Although we observed no spatial differences in the gene
expression of COL1A1 and COL2A1, the immunostaining appeared to
show a higher quantity of both type I and II collagen at the cartilage
end of the tissue. The discrepancy between the mRNA and protein
levels can be attributed to the fact that gene expression and matrix
remodeling are dynamic processes that are not always correlated in
an end-point tissue analysis [36]. Interestingly, we observed type X
collagen predominantly at the interface between the bone andFig. 5. Mineralization and mechanical analysis of engineered osteochondral tissue. (A) A
glycosaminoglycan (blue) in engineered osteochondral constructs showed mineralization sp
HAP (green), b-TCP (blue) and cells (red) also showed mineralization speciﬁcally in the bone
signal from HAP and b-TCP (945 - 975 cm1) across the length of the osteochondral tissue
Unconﬁned compression testing of the engineered osteochondral constructs showing the
neered from three different hMSC donors (denoted by red, black and blue markers). Compar
dataset was addressed (mean ± 95% conﬁdence intervals, N ¼ 3, n ¼ 3) where p < 0.05 (*). (F
to the Web version of this article.)cartilage regions, which indicated a zone of hypertrophic chon-
drocytes [37] (Fig. 4C). Furthermore, osteopontin, a key marker of
osteogenesis and biomineralization, was present exclusively in the
bone region of the tissue (Fig. 4D).
This spatially-controlled osteogenic response was further
corroborated using an alkaline phosphatase assay, which revealed a
higher enzymatic activity in the bone region, compared to the
cartilage region (Supplementary Figure 12). Alkaline phosphatase
catalyzes the hydrolysis of organic phosphates into inorganic
phosphate ions, which are used in tissue mineralization [38].
Accordingly, we further investigated the mineral formation in the
engineered tissue. Alizarin Red S staining revealed the bone region
to be comprised of dense calcium-rich nodules (Fig. 5A), while
Raman microscopy identiﬁed the presence of two distinct calcium
phosphate morphologies: hydroxyapatite (HAP) and b-tricalcium
phosphate (b-TCP) (Fig. 5B). HAP is a non-degradable and
mechanically-robust mineral, while b-TCP is a bioresorbable salt
with osteoinductive degradation products; the presence of both
morphologies is desirable during bone formation [39,40]. Impor-
tantly, in both the Alizarin Red S staining and the Raman mapping,
we detected negligible calcium phosphate in the cartilage region.
Indeed, by integrating the Raman contributions from b-TCP and
HAP, we were able to detect a sharp transition in mineral contentlizarin Red S staining of calcium deposits (red) and Alcian Blue staining of sulfated
eciﬁcally at the bone end of the tissue. Scale bars¼ 500 mm. (B) Raman microscopy of
region. Scale bars¼ 100 mm. (C) Proﬁle of Raman intensity corresponding to integrated
construct, with a bright ﬁeld microscopy image for reference. Scale bar¼ 500 mm. (D)
instantaneous modulus and the pairwise comparison between tissue constructs engi-
ison of differences were made using a one sample t-test after heteroscedasticity in the
or interpretation of the references to colour in this ﬁgure legend, the reader is referred
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chondral interface [41] (Fig. 5C, Supplementary Figure 13). This
observation was consistent with both the osteopontin immuno-
ﬂuorescence staining and the macroscopic images of the engi-
neered tissue. Finally, we assessed the mechanical properties of the
osteochondral constructs using an unconﬁned compression test
(N¼ 3). The instantaneous stress-strain response of the bone and
cartilage regions revealed a higher instantaneous modulus at the
bone end than at the cartilage end in one of the biological replicates
(Fig. 5D and Supplementary Figure 14). This observation could be
attributed to differences in matrix composition, such as the pres-
ence of mineral in the bone region [42].
Overall, our results indicate that BMP-2 signaling gradients
patterned using glycosylated SPIONs can spatially inﬂuence oste-
ogenic gene expression to generate robust osteochondral con-
structs exhibiting low-stiffness cartilage and higher stiffness
mineralized bone. Moreover, the histology, immunoﬂuorescence
staining and Raman microscopy provide a detailed picture of the
engineered osteochondral tissue. In particular, we can deﬁne three
major zones; a mineralized bone region that sharply switches into
an intermediate region of hypertrophic chondrocytes, which then
smoothly transitions into a collagen-rich cartilage region. To the
best of our knowledge, such complexity has not been demonstrated
using biphasic hydrogel systems. Interestingly, the structural
complexity of our tissue, most notably the sharp transition between
bone and cartilage followed by the region of hypertrophic chon-
drocytes, was generated from an initially smooth concentration
gradient of BMP-2. These emergent structural properties are
fascinating considering the developmental biology of the osteo-
chondral interface, in which concentration gradients of osteoin-
ductive factors produce a sharp transition (tidemark) that separates
the subchondral bone/calciﬁed cartilage from hyaline cartilage. We
hypothesize that a threshold level of BMP-2 may be required to
initiate and sustain mineralization of our tissue, which may in turn
produce a positive feedback loop whereby the deposited mineral
(HAP or resorbed b-TCP) act to further stimulate osteogenesis.
Further work is required to test this theory, information that will
provide a soundmechanistic basis for engineering of osteochondral
constructs and other structurally complex tissues using our
gradient technology. Additional work is also required for trans-
lation of this technology; in particular, the overall mechanical
properties of our tissue construct must be raised to a level that is
compatible with in vivo transplantation. More generally, clinical
translation of our gradient biomaterials will require the use of
materials, cells and media approved by the Food and Drug
Administration (FDA) and other relevant international agencies,
and the fabrication procedures to be brought in line with good
manufacturing and clinical practice (GMP/GCP) guidelines.
4. Conclusions
Any robust and relevant engineered graft must recapture the
complex hierarchical microstructure of the physiological tissue. In
this report, we introduce a novel platform based on magnetic ﬁeld
alignment that can be used to rapidly produce smooth biochemical
gradients for osteochondral tissue engineering. Speciﬁcally, the
osteogenic growth factor BMP-2 was sequestered into glycosylated
SPIONs, which were magnetically patterned across an agarose
hydrogel laden with hMSCs. Diffusion of BMP-2 from the glycosy-
lated corona provided spatially-directed osteogenesis to generate
robust osteochondral tissue constructs. The initial gradient of BMP-
2 gave rise to emergent structural features that highly resembled
the osteochondral interface: mineralized bone transitioning to
cartilage via a region of hypertrophic chondrocytes. The osteo-
chondral constructs exhibited distinct cell phenotypes(chondrocytes and osteoblasts), protein expression (presence of
osteopontin, alkaline phosphatase activity) and tissue mineraliza-
tion (presence of b-TCP and HAP mineral). Taken together, the gene
expression, biochemical proﬁle, matrix distribution and Raman
microscopy suggested that the interplay between the released
BMP-2 and the solution factors (TGF-b3, b-glycerophosphate) were
at a point where the tissue calciﬁcation could be achieved in a local
fashion governed entirely by the patterned gradient. This technol-
ogy offers great versatility and could be readily tailored to other
growth factors and hydrogel systems, offering new opportunities
for a range of interfacial tissue engineering challenges.
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